A Phase 1/2 study of the dose-response in pharmacodynamics and safety of prothrombin complex concentrate Cofact in healthy subjects under vitamin K antagonist anticoagulation
Latest Information Update: 18 Sep 2023
At a glance
- Drugs Prothrombin complex concentrate (Primary)
- Indications Haemorrhage
- Focus Therapeutic Use
- Sponsors Prothya BioSolutions
- 19 Dec 2022 Status changed from recruiting to completed.
- 04 Dec 2022 This trial has been completed in Netherlands (End Date: 9 Sep 2022) according to European Clinical Trials Database record.
- 16 Mar 2022 New trial record